Discovering Momentum Stocks: Eli Lilly and Company (LLY), Harley-Davidson, Inc. (HOG)

Marco Green
October 12, 2017

LLC now owns 3,364 shares of the company's stock worth $283,000 after purchasing an additional 50 shares in the last quarter. Finally, Zacks Investment Research upgraded Eli Lilly and from a "hold" rating to a "buy" rating and set a $94.00 price target on the stock in a research report on Monday, July 17th. The stock decreased 1.01% or $0.88 during the last trading session, reaching $86.16. Currently, 177.62 million total shares are owned by the public and among those 169.93 million shares have been available to trade. On Monday, June 12 Barnes Melissa S sold $153,482 worth of Eli Lilly and Co (NYSE:LLY) or 1,900 shares. It has underperformed by 12.00% the S&P500. Appleton Prtnrs Ma invested in 0.1% or 7,001 shares. The firm has a market capitalization of $90.79 billion, a P/E ratio of 37.24 and a beta of 0.34. Commonwealth Equity Ser invested in 0% or 10,531 shares. About 8,043 shares traded. AEGON N.V. (ADR) (NYSE:AEG) has declined 1.40% since October 11, 2016 and is downtrending. It has outperformed by 20.71% the S&P500. Eli Lilly and's revenue for the quarter was up 7.8% on a year-over-year basis. X Co Ltd has invested 0.04% in Eli Lilly and Co (NYSE:LLY).

They now have a $73 target price per share on Eli Lilly (NYSE:LLY).

Investors sentiment decreased to 0.9 in Q2 2017. Its down 0.08, from 0.98 in 2017Q1.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Comerica Financial Bank reported 302,967 shares or 0.19% of all its holdings. Rand Wealth Lc holds 8,400 shares or 0.09% of its portfolio. Wealthtrust Axiom Lc has 0.95% invested in Eli Lilly and Co (NYSE:LLY) for 30,923 shares. Envestnet Asset Management holds 0.01% or 66,682 shares. Utd Automobile Association accumulated 481,143 shares. Davidson reported 0% of its portfolio in Eli Lilly and Co (NYSE:LLY). Thrivent Fin For Lutherans invested in 0.01% or 39,070 shares. New York-based Tocqueville Asset Limited Partnership has invested 0.03% in Eli Lilly and Co (NYSE:LLY). Park Avenue Securities Ltd stated it has 4,028 shares. The original version of this story can be accessed at Morgan Stanley, a New York-based fund reported 460,416 shares. With short interest at 12,372,722 and short average daily volume at 3,088,801, days to cover is 4.0 and the short interest percentage is 0.01% as of September 29. Therefore 25% are positive. Eli Lilly and Company had 78 analyst reports since July 23, 2015 according to SRatingsIntel. Citigroup Inc. reiterated a "buy" rating and issued a $100.00 price objective on shares of Eli Lilly and in a report on Tuesday, July 4th. The firm has "Buy" rating given on Friday, August 18 by Oppenheimer. The stock now has a consensus rating of "Hold" and a consensus target price of $88.57. The firm has "Hold" rating given on Wednesday, June 14 by Jefferies. Jefferies Group LLC restated a "buy" rating and set a $93.00 price target on shares of Eli Lilly and in a research report on Thursday, June 22nd. On October 10 the company was downgraded from "Outperform" to "Neutral" by Credit Suisse. Societe Generale downgraded the shares of AEG in report on Thursday, October 13 to "Hold" rating.

On October 10 BMO Capital kept the company rating at "Underperform" and raised the price expectation from $64.00 to $73.00.

A number of other equities research analysts have also recently issued reports on LLY.

Since May 4, 2017, it had 0 insider buys, and 3 insider sales for $4.05 million activity. 25,000 shares were sold by Conterno Enrique A, worth $2.07 million on Thursday, May 4. Netherlands-based Shell Asset Management has invested 0.63% in Eli Lilly and Co (NYSE:LLY). Analysts expect that Eli Lilly and Company will post $4.16 earnings per share for the current fiscal year. LLY's profit will be $1.13B for 20.89 P/E if the $1.03 EPS becomes a reality. It turned negative, as 61 investors sold Eli Lilly and Co shares while 400 reduced holdings. Its down 0.08, from 0.98 in 2017Q1. 2,753 were reported by Graybill Bartz Assoc Limited. Bank & Trust Of Mellon Corporation stated it has 0% of its portfolio in Lumber Liquidators Holdings Inc (NYSE:LL). (NASDAQ:AMZN) for 12,472 shares.

Lumber Liquidators Holdings, a multi-channel specialty retailer of hardwood flooring, and hardwood flooring enhancements and accessories. Scholtz & Com Limited Liability Company invested in 4,319 shares or 3.61% of the stock. 5,410 are held by Gilman Hill Asset Ltd Co. 36,967 are held by Umb Retail Bank N A Mo. Asset Advisors Corporation owns 10,500 shares or 0.16% of their USA portfolio. It fall, as 6 investors sold Marinus Pharmaceuticals Inc shares while 7 reduced holdings. State Board Of Administration Of Florida Retirement holds 0.05% or 293,173 shares. (NASDAQ:AMZN) for 259 shares. Sigma Planning reported 0.11% stake. Gm Advisory Group Incorporated Inc holds 2,330 shares. Panagora Asset Mgmt owns 0% invested in Marinus Pharmaceuticals Inc (NASDAQ:MRNS) for 3,573 shares. Norinchukin Bancorporation The accumulated 119,335 shares. Osborne Partners owns 18,565 shares or 0.17% of their United States portfolio.

Since May 2, 2017, it had 0 buys, and 13 sales for $960.72 million activity. $478,028 worth of, Inc. Its down 18.58% from 6.96M shares previously. $3.88 million worth of, Inc.

Checchi Capital Advisers Llc, which manages about $305.00M and $920.33M US Long portfolio, decreased its stake in Celgene Corp (NASDAQ:CELG) by 2,536 shares to 5,605 shares, valued at $728,000 in 2017Q2, according to the filing.

Other reports by Click Lancashire

Discuss This Article